!!Projects per year
個人檔案
學歷
- 2012 國立成功大學基礎醫學研究所博士
- 2007 國立成功大學生理學研究所碩士
- 2004 中臺科技大學醫學影像暨放射科學系學士
經歷
- 2025- 臺北醫學大學神經再生醫學博士學位學程教授
- 2022-2025 臺北醫學大學神經再生醫學博士學位學程副教授
- 2019-2022 臺北醫學大學神經再生醫學博士學位學程助理教授
- 2018-2019 臺北醫學大學神經醫學研究中心助理研究員
- 2017-2019 臺北醫學大學神經再生醫學博士學位學程助理研究員
- 2016-2018 臺北醫學大學神經損傷及再生研究中心助理研究員
- 2012-2015 國立成功大學傳染性疾病與訊息研究中心博士後研究員
獎項
- 2014科技部103年度博士後研究優秀論文獎
- 2012 成功大學醫學院博士班優秀論文獎
研究興趣
- 腫瘤生物學
- 癌症小鼠模式
相關連結
指紋
查看啟用 Tsung-I Hsu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
- 7 類似的個人檔案
過去五年中的合作和熱門研究領域
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
專案
- 22 已完成
-
探討膠質母細胞瘤腫瘤生態系統並開發新穎治療策略－MIF在抑制mTOR介導的代謝重編程中對NK細胞功能失調的角色(1/3)
Hsu, T.-I. (PI)
8/1/25 → 7/31/26
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
針對膠質母細胞瘤的治療抵抗力：黃體酮透過調節蛋白質唾液酸化增強化療和免疫治療反應的作用(2/3)
Hsu, T.-I. (PI)
8/1/25 → 7/31/26
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
替莫唑胺結合美金剛胺之衍生藥物對於膠質母細胞瘤與星狀細胞瘤的治療效果與機制探討
Hsu, T.-I. (PI)
7/1/25 → 2/28/26
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
利用介孔二氧化矽奈米顆粒對抗由SPP1介導的免疫抑制並增強NK細胞成熟中的mTOR信號以對抗膠質母細胞瘤
Hsu, T.-I. (PI)
3/1/25 → 2/28/26
研究計畫: C - 校外計畫 › o - 奇美醫院
-
Evaluating the Potential Efficacy of Gamma-Delta (γδ) T Cell Therapy on Hepatocellular Carcinoma
Hsu, T.-I. (PI) & Shen, C.-J. (CoPI)
3/1/25 → 2/28/26
研究計畫: D - 其他計畫
-
Dual suppression of stemness and redox adaptation in glioblastoma through filaggrin upregulation by an abiraterone-based HDAC inhibitor
Tran, H. Y., Sharma, R., Lin, H.-Y., Yeh, T.-Y., Shen, C.-J., Hsu, T.-I. & Liou, J.-P., 12月 2026, 於: Journal of Biomedical Science. 33, 1, 38.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Targeting the COX-2/PGE2 axis to enhance NK and T cell immunotherapy in brain tumors
Shen, C.-J., Florentino-Krasnov, J., Liao, Y.-C., Tang, H.-W., Nainggolan, B. W. M., Chiang, Y.-H. & Hsu, T.-I., 5月 2026, 於: Cancer Immunology, Immunotherapy. 75, 5, 141.研究成果: 雜誌貢獻 › 回顧型文獻 › 同行評審
開啟存取1 連結會在新分頁中打開 引文 斯高帕斯（Scopus） -
Unmodified γδ T cells exhibit potent antitumor activity in hepatocellular carcinoma and are enhanced by PD-L1 blockade
Zhang, B.-X. B., Lin, H.-Y., Tran, H. Y., Wu, C.-C., Chen, K.-Y., Hsu, T.-I. & Shen, C.-J., 3月 2026, 於: Immunobiology. 231, 2, 153163.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
A Dual CYP17A1/HDAC6 Inhibitor for Targeted Prostate Cancer Therapy
Tran, H. Y., Lin, C. L., Lin, H. Y., Shen, C. J., Sharma, R., Liou, J. P. & Hsu, T. I., 10月 2025, 於: FASEB Journal. 39, 20, e71152.研究成果: 雜誌貢獻 › 文章 › 同行評審
1 連結會在新分頁中打開 引文 斯高帕斯（Scopus） -
Contribution of Prostaglandin E2-Induced Neuronal Excitation to Drug Resistance in Glioblastoma Countered by a Novel Blood–Brain Barrier Crossing Celecoxib Derivative
Shen, C. J., Chen, H. C., Lin, C. L., Thakur, A., Onuku, R., Chen, I. C., Li, H. Y., Chang, K. Y., Chuang, J. Y., Yang, W. B., Lin, H. Y., Shen, Y. R., Liou, J. P., Chang, W. C. & Hsu, T. I., 10月 13 2025, 於: Advanced Science. 12, 38, e06336.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取9 連結會在新分頁中打開 引文 斯高帕斯（Scopus）
資料集
-
CCAAT/enhancer-binding protein delta regulates the stemness of glioma stem-like cells through activating PDGFA expression upon inflammatory stimulation
Wang, S.-M. (Creator), Lin, H.-Y. (Creator), Chen, Y.-L. (Contributor), Hsu, T.-I. (Contributor), Chuang, J.-Y. (Creator), Kao, T.-J. (Contributor) & Ko, C.-Y. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.c.4575326.v1, https://doi.org/10.6084%2Fm9.figshare.c.4575326.v1
資料集: Dataset
-
Reprogramming of arachidonate metabolism confers temozolomide resistance to glioblastoma through enhancing mitochondrial activity in fatty acid oxidation
Tsai, Y.-T. (Creator), Lo, W.-L. (Creator), Chen, P.-Y. (Creator), Ko, C.-Y. (Creator), Chuang, J.-Y. (Creator), Kao, T.-J. (Creator), Yang, W.-B. (Creator), Chang, K.-Y. (Creator), Hung, C.-Y. (Creator), Kikkawa, U. (Creator), Chang, W.-C. (Creator) & Hsu, T.-I. (Creator), Figshare, 2022
DOI: 10.6084/m9.figshare.c.5916320.v1, https://springernature.figshare.com/collections/Reprogramming_of_arachidonate_metabolism_confers_temozolomide_resistance_to_glioblastoma_through_enhancing_mitochondrial_activity_in_fatty_acid_oxidation/5916320/1
資料集: Dataset
-
Additional file 1 of Reprogramming of arachidonate metabolism confers temozolomide resistance to glioblastoma through enhancing mitochondrial activity in fatty acid oxidation
Tsai, Y.-T. (Creator), Lo, W.-L. (Creator), Chen, P.-Y. (Creator), Ko, C.-Y. (Creator), Chuang, J.-Y. (Creator), Kao, T.-J. (Creator), Yang, W.-B. (Creator), Chang, K.-Y. (Creator), Hung, C.-Y. (Creator), Kikkawa, U. (Creator), Chang, W.-C. (Creator) & Hsu, T.-I. (Creator), Figshare, 2022
DOI: 10.6084/m9.figshare.19425032.v1, https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Reprogramming_of_arachidonate_metabolism_confers_temozolomide_resistance_to_glioblastoma_through_enhancing_mitochondrial_activity_in_fatty_acid_oxidation/19425032/1
資料集: Dataset
-
MOESM2 of Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets
Chen, P.-Y. (Contributor), Yang, W.-B. (Creator), Chou, S.-W. (Creator), Yang, S.-T. (Creator), Chung, P.-H. (Contributor), Chang, K.-Y. (Contributor), Liu, M.-S. (Creator), Chen, S.-H. (Contributor), Chien, C.-H. (Contributor), Hsu, T.-I. (Contributor), Chu, J.-M. (Contributor), Huang, C.-Y. (Contributor), Yang, K.-Y. (Creator), Liu, J.-J. (Creator), Chuang, J.-Y. (Creator) & Lo, W.-L. (Creator), Figshare, 2019
DOI: 10.6084/m9.figshare.10006850.v1, https://doi.org/10.6084%2Fm9.figshare.10006850.v1
資料集: Dataset
-
MOESM7 of Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets
Chou, S.-W. (Creator), Chen, P.-Y. (Contributor), Chu, J.-M. (Contributor), Chien, C.-H. (Contributor), Liu, J.-J. (Creator), Liu, M.-S. (Creator), Chuang, J.-Y. (Creator), Chung, P.-H. (Contributor), Hsu, T.-I. (Contributor), Chen, S.-H. (Contributor), Yang, S.-T. (Creator), Lo, W.-L. (Creator), Huang, C.-Y. (Contributor), Chang, K.-Y. (Contributor), Yang, K.-Y. (Creator) & Yang, W.-B. (Creator), Figshare, 2019
DOI: 10.6084/m9.figshare.10006880.v1, https://doi.org/10.6084%2Fm9.figshare.10006880.v1
資料集: Dataset